Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 70651-70700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05816798
Photobiomodulation in Chronic Knee Pain in Patients Who Are in PreRehabilitation for Bariatric Surgery
PHASE2/PHASE3
Recruiting
62 participants
Started: Jul 28, 2023 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT05700656
Galunisertib Combined With Capecitabine in Advanced CRC With PM
PHASE1/PHASE2
Recruiting
31 participants
Started: Jul 28, 2023 · Completed: Apr 30, 2025
2 conditions
2 sponsors
2 locations
NCT05992883
NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis
PHASE3
Recruiting
240 participants
Started: Jul 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05976412
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
NA
Recruiting
1,355 participants
Started: Jul 28, 2023 · Completed: May 31, 2031
1 condition
1 sponsor
1 location
NCT05686356
A Pan-TB Regimen Targeting Host and Microbe
PHASE2/PHASE3
Active, not recruiting
352 participants
Started: Jul 28, 2023 · Completed: Jan 31, 2026
1 condition
9 sponsors
8 locations
NCT05853458
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
PHASE4
Active, not recruiting
76 participants
Started: Jul 28, 2023 · Completed: Jan 27, 2027
1 condition
1 sponsor
26 locations
NCT04977167
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
PHASE1
Recruiting
96 participants
Started: Jul 28, 2023 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05899933
Comparison of the Effectiveness of Two Different Surgical Therapeutic Protocols of Peri-implantitis
NA
Recruiting
45 participants
Started: Jul 28, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05970627
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
PHASE2
Not yet recruiting
30 participants
Started: Jul 28, 2023 · Completed: Jul 28, 2029
3 conditions
1 sponsor
8 locations
NCT05942352
Clinical Study of Ligustrazine in Treating Alcohol Addiction
PHASE4
Recruiting
400 participants
Started: Jul 28, 2023 · Completed: Jul 31, 2024
2 conditions
1 sponsor
1 location
NCT05956834
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
N/A
Recruiting
60 participants
Started: Jul 28, 2023 · Completed: Dec 30, 2026
7 conditions
3 sponsors
2 locations
NCT05917509
A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
PHASE3
Active, not recruiting
171 participants
Started: Jul 28, 2023 · Completed: Sep 3, 2026
1 condition
3 sponsors
47 locations
NCT05798507
Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
EARLY_PHASE1
Active, not recruiting
14 participants
Started: Jul 28, 2023 · Completed: Oct 31, 2026
2 conditions
3 sponsors
1 location
NCT05623397
A Deep Learning Method to Evaluate QT on Ribociclib
N/A
Recruiting
70 participants
Started: Jul 28, 2023 · Completed: Sep 28, 2026
2 conditions
1 sponsor
4 locations
NCT06560801
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
PHASE4
Recruiting
48 participants
Started: Jul 28, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06792435
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
PHASE1/PHASE2
Recruiting
240 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2025
7 conditions
1 sponsor
1 location
NCT06925815
Pregnancy Cohort Study: Pregnancy as a Window to Future Health
N/A
Recruiting
800 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2034
3 conditions
1 sponsor
1 location
NCT06072872
Portable Continuous Positive Airways Pressure (CPAP) in Excessive Central Airway Collapse (ECAC) Study
NA
Recruiting
20 participants
Started: Jul 27, 2023 · Completed: Jul 31, 2024
4 conditions
1 sponsor
1 location
NCT06042049
A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab
PHASE3
Active, not recruiting
33 participants
Started: Jul 27, 2023 · Completed: Aug 15, 2025
1 condition
2 sponsors
9 locations
NCT06227117
Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer
PHASE2
Recruiting
120 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
5 locations
NCT06185803
Predictors of Anterior Patellofemoral Pain After Anterior Cruciate Ligament Reconstruction
N/A
Active, not recruiting
500 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05036538
Decreasing Preoperative Stress to Prevent Postoperative Delirium and Postoperative Cognitive Decline in Cardiac Surgical Patients.
NA
Recruiting
125 participants
Started: Jul 27, 2023 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT06007170
Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients Without Glottal Enlargement
NA
Recruiting
20 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
6 locations
NCT05978141
A Registry for People With T-cell Lymphoma
N/A
Recruiting
1,000 participants
Started: Jul 27, 2023 · Completed: Jul 27, 2030
31 conditions
1 sponsor
26 locations
NCT05495906
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
PHASE4
Recruiting
450 participants
Started: Jul 27, 2023 · Completed: Jan 31, 2028
3 conditions
1 sponsor
10 locations
NCT05638581
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
PHASE3
Recruiting
1,100 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2027
2 conditions
3 sponsors
13 locations
NCT05953155
YOga for Patients with Chronic BACK Pain and Poor PROgnosis
NA
Recruiting
110 participants
Started: Jul 27, 2023 · Completed: Jul 30, 2027
4 conditions
1 sponsor
1 location
NCT05709210
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.
NA
Recruiting
90 participants
Started: Jul 27, 2023 · Completed: Feb 15, 2024
2 conditions
2 sponsors
1 location
NCT07193316
Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis
N/A
Active, not recruiting
741 participants
Started: Jul 27, 2023 · Completed: Oct 31, 2025
2 conditions
1 sponsor
1 location
NCT05989711
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
PHASE2
Active, not recruiting
190 participants
Started: Jul 27, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
40 locations
NCT05957848
Guanfacine Extended-release for Adolescents With Cannabis Use
PHASE2
Recruiting
100 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT06367959
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
NA
Recruiting
192 participants
Started: Jul 27, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT05978557
Brain Slice Explants to Predict Drug Response in Brain Tumors
N/A
Recruiting
50 participants
Started: Jul 27, 2023 · Completed: Mar 1, 2028
1 condition
1 sponsor
1 location
NCT05725564
Testing Interventions for Mobility Through Exercise (TIME)
NA
Recruiting
620 participants
Started: Jul 27, 2023 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT06680284
Toronto Western Hospital (TWH) Waste Audit
N/A
Recruiting
60 participants
Started: Jul 27, 2023 · Completed: Dec 20, 2025
1 condition
1 sponsor
1 location
NCT05630066
A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.
PHASE2
Active, not recruiting
48 participants
Started: Jul 27, 2023 · Completed: Dec 4, 2025
1 condition
1 sponsor
20 locations
NCT05949593
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
PHASE3
Recruiting
429 participants
Started: Jul 27, 2023 · Completed: Nov 30, 2027
1 condition
1 sponsor
49 locations
NCT05918640
Lurbinectedin in FET-Fused Tumors
PHASE1/PHASE2
Recruiting
63 participants
Started: Jul 27, 2023 · Completed: Jul 30, 2028
4 conditions
3 sponsors
6 locations
NCT05230134
Cervical Sympathetic Block in Patients With Cerebral Vasospasm
NA
Enrolling by invitation
10 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT06054373
The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases
N/A
Recruiting
150 participants
Started: Jul 27, 2023 · Completed: Sep 30, 2024
2 conditions
2 sponsors
1 location
NCT06324513
Evaluation of the Efficacy and Tolerability of the Mediterranean Diet Pattern in the Exclusion Diet for Patients With Crohn's Disease.
NA
Recruiting
120 participants
Started: Jul 27, 2023 · Completed: Oct 27, 2025
1 condition
1 sponsor
3 locations
NCT05608668
Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma
NA
Recruiting
60 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT05585281
A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
PHASE2
Recruiting
25 participants
Started: Jul 27, 2023 · Completed: Dec 22, 2025
1 condition
1 sponsor
1 location
NCT05391113
REward SYSTem in Autism Spectrum Disorder and Addictive Disorder
NA
Recruiting
78 participants
Started: Jul 27, 2023 · Completed: Jan 27, 2027
1 condition
2 sponsors
3 locations
NCT05998928
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
PHASE2
Recruiting
10 participants
Started: Jul 27, 2023 · Completed: Jul 27, 2026
1 condition
2 sponsors
1 location
NCT05978492
A Study of TXN10128 in Subjects With Solid Tumors
PHASE1
Recruiting
96 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
6 locations
NCT05778188
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
PHASE2
Recruiting
42 participants
Started: Jul 27, 2023 · Completed: Apr 30, 2026
1 condition
2 sponsors
15 locations
NCT05568550
Pembro With Radiation With or Without Olaparib
PHASE2
Recruiting
64 participants
Started: Jul 27, 2023 · Completed: Jul 2, 2029
1 condition
2 sponsors
2 locations
NCT06171191
Move ARound And Get Active: an Intervention to Optimize 24-hour Movement Behaviours in Preschoolers
NA
Recruiting
200 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2024
8 conditions
5 sponsors
4 locations
NCT05375474
Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR
PHASE4
Recruiting
650 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
Previous
1
More pages
1411
1412
1413
1414
1415
1416
1417
More pages
2369
Next